Aurobindo Pharma P/E Ratio
Aurobindo Pharma (AUROPHARMA) P/E ratio is 25.44 (High), EPS (TTM) ₹60.34, current price ₹1532.00 on NSE vs historical average P/E of 16.78 (100.0th percentile) — High - Growth expectations or overvalued. See AUROPHARMA price to book ratio to compare market price against book value per share.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
AUROPHARMA P/E Ratio — Valuation Signal & Historical Context
Aurobindo Pharma P/E 25.44 vs historical average 16.78, range 4.98–22.54 — signal: Overvalued. Read AUROPHARMA dividend payout details for the complete payout history and dividend yield track record.
- Stock appears overvalued with PE of 25.44, suggesting caution for new investments
- Current PE is 51.6% above historical average
- Trading at discount to sector average PE of 55.8
Aurobindo Pharma P/E Ratio Historical Trend
AUROPHARMA annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 25.44 vs historical average 16.78. For live price, revenue and the complete fundamental profile, see AUROPHARMA stock price BSE.
AUROPHARMA Historical P/E Ratio — EPS, Year-End Price & Valuation
Aurobindo Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 22.54 | 60.04 | ₹1353.25 | NSE | Moderate |
| 2024 | 18.07 | 59.76 | ₹1080.15 | NSE | Moderate |
| 2023 | 9.2 | 47.25 | ₹434.80 | NSE | Low |
| 2022 | 21.48 | 34.09 | ₹732.10 | NSE | Moderate |
| 2021 | 18.93 | 49.02 | ₹927.75 | NSE | Moderate |
| 2020 | 4.98 | 91.91 | ₹458.10 | NSE | Low |
| 2019 | 16.74 | 43.8 | ₹733.15 | NSE | Moderate |
| 2018 | 17.36 | 39.39 | ₹683.95 | NSE | Moderate |
| 2017 | 16.3 | 41.44 | ₹675.50 | NSE | Moderate |
| 2016 | 22.16 | 39.77 | ₹881.40 | NSE | Moderate |
AUROPHARMA vs Healthcare Peers — P/E Ratio Comparison
Aurobindo Pharma P/E 25.44 vs Healthcare average 55.8, median 31.44 — range 2.86–916.67.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.61 | ₹64 | Low |
| Sunrest Lifescience | SUNREST | 3.76 | ₹30 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.76 | ₹7,399 | Low |
| Shelter Pharma | SHELTER | 5.23 | ₹47 | Low |
| Dipna Pharmachem | DPL | 5.39 | ₹14 | Low |
| JFL Life Sciences | JFLLIFE | 5.41 | ₹68 | Low |
| Amwill Health Care | AMWILL | 7.26 | ₹83 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹84 | Low |
| Galaxy Medicare | GML | 7.8 | ₹27 | Low |